The Latest Breaking News from MaxLinear

Chipmaker MaxLinear has now countersued the cable company, claiming it stole its Full-Duplex DOCSIS technology trade secrets

Chipmaker Intel beat Wall Street's targets for the third quarter and guided higher than estimates for the current period.

Chipmaker Macom Technology Solutions narrowly beat Wall Street's targets for its fiscal first quarter but offered mixed guidance.

With the Fed indicating that the pace of rate hikes might slow down, growth stocks could see a rebound. Therefore, it could be wise to buy CVS Health (CVS), Archer-Daniels-Midland (ADM), The Mosaic Company (MOS), and MaxLinear (MXL), which possess solid growth attributes. Keep reading….

One of the seven criteria in the CAN SLIM method of investing is institutional sponsorship. Institutional investors include major entities such as pension funds, hedge funds, insurance companies and mutual funds. Increased institutional ownership is considered positive for a stock. A screen called Stocks Funds Are Buying, found in the…

Merger activity decreased last week with three new deals announced and four deals completed. Two of the three deals announced were potential deals in the works. We saw yet another SPAC business combination fall apart. Black Knight (NYSE: BKI)

The stock market plunged Thursday in a belated reaction to the Fed moves; technology and consumer discretionary stocks led the decline.

Chipmaker MaxLinear on Thursday announced plans to buy Silicon Motion in a cash-and-stock deal worth $3.8 billion.

Indexes gave back most of the prior day's big gains. The Nasdaq plunged 2.8%.

According to Benzinga Pro, during Q1, MaxLinear (NASDAQ:MXL) earned $33.59 million, a 19.2% increase from the preceding quarter. MaxLinear also posted a total of $263.93 million in sales, a 6.47% increase since Q4.

Within the last quarter, MaxLinear (NASDAQ:MXL) has observed the following analyst ratings: